US Patent Issued to BLUE LAKE BIOTECHNOLOGY on Nov. 3 for "Recombinant RSV vaccine: methods of making and using the same" (Georgia, California Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,029, issued on Nov. 3, was assigned to BLUE LAKE BIOTECHNOLOGY INC. (Athens, Ga.).

"Recombinant RSV vaccine: methods of making and using the same" was invented by Biao He (Athens, Ga.), Hong Jin (Cupertino, Calif.) and Maria Cristina Gingerich (Athens, Ga.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions and methods of inducing an immune response in a subject having RSV comprising administering a pharmaceutical composition comprising a prophylactic vaccine against RSV infection, wherein the vaccine comprises a live recombinant canine parainfluenza (CPI) vector backbone engineered to express a RSV F protein."

The patent was filed on Nov. 3...